Literature DB >> 9018130

Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells.

H Schneider1, K Kaelin, M A Billeter.   

Abstract

The measles virus (MV) phosphoprotein (P) gene encodes three proteins, P, C, and V. The V protein is synthesized by pseudo-templated transcription, also designated as RNA editing: during P gene transcription one G residue is inserted at a defined position in about 50% of the mRNAs. To study the importance of sequence elements for the nontemplated G insertion, we generated recombinant MVs in which six different mutations were introduced within the region where editing occurs (3' UUUUUCCC, template strand). These viruses were then analyzed for their ability to edit their P mRNA and to produce V protein. Single U to C changes within the U stretch abolished editing. Extending the template by three C residues at the site of G insertion resulted in a less precise editing phenotype and overproduction of V. None of these mutants were impaired in their multiplication behavior when analyzed in cultured cells. However, the syncytia of a recombinant MV overproducing V protein were in general smaller and lysed 1 to 2 days later than usual.

Mesh:

Substances:

Year:  1997        PMID: 9018130     DOI: 10.1006/viro.1996.8339

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  The versatility of paramyxovirus RNA polymerase stuttering.

Authors:  S Hausmann; D Garcin; C Delenda; D Kolakofsky
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.

Authors:  A Bermingham; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Polyploid measles virus with hexameric genome length.

Authors:  Monika Rager; Sompong Vongpunsawad; William Paul Duprex; Roberto Cattaneo
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

5.  Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression.

Authors:  David Laine; Marie-Claude Trescol-Biémont; Sonia Longhi; Geneviève Libeau; Julien C Marie; Pierre-Olivier Vidalain; Olga Azocar; Adama Diallo; Bruno Canard; Chantal Rabourdin-Combe; Hélène Valentin
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 6.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

7.  A highly attenuated measles virus vaccine strain encodes a fully functional C protein.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

Review 8.  Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.

Authors:  D Kolakofsky; T Pelet; D Garcin; S Hausmann; J Curran; L Roux
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys.

Authors:  Patricia Devaux; Gregory Hodge; Michael B McChesney; Roberto Cattaneo
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.